Jesus M. Prieto Valtueña-rekin lankidetzan egindako argitalpenak (8)

2011

  1. Prognosis of hepatocellular carcinoma in relation to treatment across BCLC stages

    Annals of Surgical Oncology, Vol. 18, Núm. 7, pp. 1964-1971

2009

  1. Usefulness of a program of neoplasia surveillance in liver transplantation. A preliminary report

    Clinical Transplantation, Vol. 23, Núm. 4, pp. 532-536

2008

  1. Liver transplantation in patients with hepatocellular carcinoma across Milan criteria

    Liver Transplantation, Vol. 14, Núm. 3, pp. 272-278

2005

  1. De novo neoplasia after liver transplantation: An analysis of risk factors and influence on survival

    Liver Transplantation, Vol. 11, Núm. 1, pp. 89-97

  2. IFN-α gene therapy for woodchuck hepatitis with adeno-associated virus: Differences in duration of gene expression and antiviral activity using intraportal or intramuscular routes

    Molecular Therapy, Vol. 12, Núm. 1, pp. 68-76

2004

  1. Herpes zoster after liver transplantation: Incidence, risk factors, and complications

    Liver Transplantation, Vol. 10, Núm. 9, pp. 1140-1143

2003

  1. Conversion from calcineurin inhibitors to mycophenolate mofetil in liver transplant recipients with diabetes mellitus

    Transplantation Proceedings

  2. Liver Transplant Recipients Older Than 60 Years Have Lower Survival and Higher Incidence of Malignancy

    American Journal of Transplantation, Vol. 3, Núm. 11, pp. 1407-1412